Henry Schein, Inc.
Financials
Valuation Metrics
Henry Schein, Inc.'s Market Cap is $9.65B. At end of 2025 it was $8.87B. Ranked #938 of 3,116 in US market (top 30%), #298 of 1,472 on NASDAQ (top 20%), #71 of 203 in Health Care Equipment & Services (top 35%) by Market Cap.
Investment Metrics(as of 2026-11-02)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $9.65B | US#938/3,116 Sec#71/203 |
| Revenue | $13.60B | US#453/3,116 Sec#31/203 |
| Net Income | $403M | US#940/3,116 Sec#51/203 |
| Total Assets | $11.38B | US#919/3,116 Sec#44/203 |
| Net Assets | $3.16B | US#936/3,116 Sec#47/203 |
| Employees | 25,000 | US#450/3,116 Sec#33/203 |
| Value | ||
| P/E | 23.93x | US#1,340/3,116 Sec#39/203 |
| P/B | 3.06x | US#1,784/3,116 Sec#91/203 |
| PEG | 6.65x | US#1,196/3,116 Sec#64/203 |
| P/S | 0.71x | US#483/3,116 Sec#35/203 |
| EV/EBITDA | 12.90x | US#1,225/3,116 Sec#38/203 |
| FCF Yield | 5.59% | US#1,259/3,116 Sec#54/203 |
| Profitability | ||
| ROE | 12.77% | US#1,079/3,116 Sec#52/203 |
| ROA | 3.54% | US#1,302/3,116 Sec#85/203 |
| Op. Margin | 5.69% | US#1,899/3,116 Sec#104/203 |
| Revenue Growth | 6.49% | US#1,609/3,116 Sec#116/203 |
| Earnings Growth | 3.60% | US#1,208/3,116 Sec#69/203 |
| Financial Health | ||
| Debt Ratio | 210.90% | US#1,829/3,116 Sec#155/203 |
| Total Debt | $3.81B | US#817/3,116 Sec#38/203 |
| FCF | $539M | US#866/3,116 Sec#50/203 |
| Cash | $157M | US#1,919/3,116 Sec#116/203 |
| Current Ratio | 1.32x | US#1,859/3,116 Sec#162/203 |
| Net Debt/EBITDA | 3.55x | US#1,750/3,116 Sec#111/203 |
| Performance | ||
| 1Y Return | 36.95% | US#710/3,116 Sec#68/203 |
| 1M Return | 1.97% | US#1,666/3,116 Sec#146/203 |
| From 52W High | -6.11% | US#574/3,116 Sec#69/203 |
| 1Y MDD | -17.23% | US#436/3,116 Sec#11/203 |
| Trading | ||
| Volume | 2,034,276 shares | US#1,803/3,116 Sec#125/203 |
| Trading Value | $176M | US#1,183/3,116 Sec#93/203 |
| Per Share | ||
| EPS | $3.62 | US#933/3,116 Sec#50/203 |
| BPS | $28.33 | US#935/3,116 Sec#55/203 |
Company Info
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The Global Distribution and Value-Added Services segment distributes infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, gypsum, acrylics, articulators, abrasives, PPE products, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as provides equipment repair services, financial services on a non-recourse basis, continuing education services for practitioners, consulting, and other services. It also markets and sells a portfolio of consumable merchandise under its own corporate brand. The Global Specialty Products segment engage in manufacturing, marketing, and sales of dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products, and other health care-related products and services. The Global Technology segment is involved in the development and distribution of practice management software, e-services, and other products which are distributed to health care providers. The company serves dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics, home health providers, and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.